Trial intelligence / Profile preview

EXPAREL brachial plexus block for postsurgical analgesia after shoulder surgery

2015-005228-24Phase 3Completed

Sponsor
Pacira BioSciences
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Pacira BioSciences. Primary endpoint: AUC of VAS pain intensity scores through 48 hours. Started Apr 2016; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2015-005228-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005228-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call